Neumora Therapeutics, Inc. (NMRA)

NMS – Real Time Price. Currency in USD

1.70

-0.01 (-0.29%)

Market open: Aug 12, 2026, 3:42 PM EDT

1.65

-0.05 (-2.80%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-208K

-631K

-668K

-3M

Gross Profit

-208K

-631K

-668K

-3M

Operating expenses (excl. COGS)

-236M

-263M

-188M

-120M

Operating Income

-236M

-263M

-188M

-123M

Non-operating income, total

-642K

20M

-47M

-8M

Pretax income

-237M

-244M

-236M

-131M

Equity in earnings

Taxes

-130K

-178K

-268K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-237M

-244M

-236M

-131M

Discontinued operations

Net income

-237M

-244M

-236M

-131M

Dilution adjustment

Preferred dividends

Neumora Therapeutics, Inc. (NMRA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Neumora Therapeutics, Inc. (NMRA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Neumora Therapeutics, Inc. (NMRA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Neumora Therapeutics, Inc. (NMRA)

Income Statement (Annual)

Income Statement (Annual)